Slideshow

5 Top 2017 Diabetes-CV Outcomes Studies

Five studies on the impact of diabetes drugs on CV outcomes get the editors' nod for the most promising results in 2017 diabetes research. Find out which 5! 

Five studies that evaluated the impact on cardiovascular outcomes of traditional and newer diabetes drugs are the Patient Care editors' choice for the most promising results in 2017 diabetes research.Click through the slides above for at-a-glance summaries of:CVD REAL CANVAS REMOVAL DEVOTE ODYSSEY-DM-INSULINLEADER (CV, renal)

Related Videos
Viet Le, DMSc, PA-C | Credit: APAC
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
HCPLive CKD and CVD NewsNetwork Thumbnail
Richard Pratley, MD | Credit: Advent Health Diabetes Institute
Rahul Aggarwal, MD | Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.